Citadel Advisors »

Vistagen Therapeutics Ord shares owned by Citadel Advisors

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 391k 3.01
2024-06-30 $2.5M 706k 3.48
2024-03-31 $4.3M 821k 5.28
2023-12-31 $4.2M 817k 5.14
2023-09-30 $358k 68k 5.24
2023-06-30 $37k 20k 1.87

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Vistagen Therapeutics Ord

BVF
Stempoint Capital
Vanguard Group
Commodore Capital
Nantahala Capital Management
Sphera Funds Management
Dr. Jeffrey R. Jay, M.D.
BlackRock
BlackRock
Citadel Advisors
Armistice Capital
Geode Capital Management
Susquehanna International
Renaissance Technologies
Goldman Sachs Group

View all funds holding Vistagen Therapeutics Ord